ACRS vs NVDA · rev $3.6M vs P/E 58, rev $215.94B
Aclaris Therapeutics Inc (ACRS) versus NVIDIA Corporation (NVDA) — a side-by-side from cached financials, not a winner call.
Aclaris Therapeutics Inc (ACRS) is a biotechnology company listed on NASDAQ.
NVIDIA Corporation (NVDA) is a semiconductors company listed on US. It is led by Jen-Hsun Huang.
Latest reported ACRS revenue for 2026-06-30 was $3.6M. Net income was -$41.3M. Revenue was up 81.6% from 2026-03-31 to 2026-06-30. ACRS currently screens at market cap $615.9M.
Latest reported NVDA revenue for 2026-01-25 was $215.94B. Net income was $120.07B. NVDA currently screens at market cap $4.40T and trailing P/E 58.2.
ACRS currently screens at market cap $615.9M. NVDA currently screens at market cap $4.40T and trailing P/E 58.2.
Not investment advice. Open the ACRS and NVDA stock pages for the full models.
Not investment advice.